Axon (AXON) – FDA
-
Axovant Sciences (AXON) Gains Ahead of JPMorgan Conference
-
Axovant Sciences (AXON) Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from UMass
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AXON Stock Lookup